Endometriosis III and IV as a risk factor for tubal obstruction in infertile women

other OA: gold CC-BY-4.0
AI-generated summary by qwen3.7-flash, 2026-08-31

This case-control study of 144 infertile women found no statistically significant association between stage III or IV endometriosis and tubal obstruction, despite an odds ratio of 2.5.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by qwen3.7-flash, 2026-08-31 · read from full text

This study investigated whether advanced endometriosis stages III and IV serve as risk factors for tubal obstruction in infertile women through a case-control analysis of 144 patients. The results indicated that while the odds ratio for tubal obstruction was higher in women with severe endometriosis, the difference did not reach statistical significance due to the small sample size. The authors explicitly note that further research with larger datasets is required to confirm these preliminary associations between disease stage and tubal pathology. This paper is centrally about endometriosis — specifically examining its association with tubal obstruction as a cause of infertility.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

OBJECTIVE: A previous study carried out among infertile women with tubal obstruction identified a relative risk of 2.5 for Chlamydia trachomatis seropositivity. However, endometriosis may also be associated with increased risk. This study aimed to evaluate the risk of tubal obstruction associated with endometriosis III/IV among women submitted to assisted reproductive procedures. METHODS: A case-control study was performed among 144 women with and without tubal obstruction. We calculated the odds ratio with 95% CI regarding the association of endometriosis III/IV and tubal obstruction. Calculations were performed using the SPSS v.17.0 package. RESULTS: The mean age was 33.7 years (4.76 SD), and the mean infertility duration time was 66.7 months (120.6 SD). The total prevalence of endometriosis was 20/144 (13%). Among 144 women, the risk group with tubal obstruction and endometriosis III/IV comprised 7out of 20 (35%), compared with the group without such risk, that comprised 22 out of 124 (17%). The X2 test was 3.19 with a p-value of 0.07. The odds ratio (OR) was 2.5 (95% CI: 0.647-9.639). CONCLUSION: Although the OR was 2.5, there was no significant difference between the groups with and without endometriosis III/IV. Further studies are needed to increase the sample size.
Full text 7,045 characters · extracted from pmc-nxml · 5 sections · click to expand

Intro

The prevalence of infertility in patients with endometriosis varies depending on the author. Some have reported that 25-50% of women with infertility have endometriosis, and about 30-50% of the women with endometriosis have infertility ( Hickey et al. , 2014 ). Between 10 and 15 % of all women seek IVF in the UK due to tubal infertility ( HFEA, 2016 ). In this cases, the cause may be pelvic inflammatory disease, endometriosis, salpingitis isthmica nodosa, polyps and surgical trauma ( Honoré et al., 1999 ). Tanahatoe et al. (2003) found 10 % of infertility in endometriosis. These authors also found that the most important causes of infertility in couples are ovulation disorders, tubal obstruction and semen abnormalities (mainly azoospermia, oligozoospermia, teratozoospermia and astenozoospermia). This causes account for approximately 75% of infertility in couples. The remaining is so far unknown ( Tanahatoe et al., 2003 ). Mild or moderate endometriosis is related to subfertility with pregnancy rates of 17.7% at nine months of follow-up. Endometriosis is a net factor of subfertility, mainly in stages III and IV. In a series of cases, a fertility rate of 3% has been reported after 12 months in cases of stage IV endometriosis ( Marcoux et al., 1997 ). It is a disease that can affect several organs, such as the pelvic peritoneum, fallopian tubes, ovaries, subcutaneous tissue, umbilicus, urinary tract, bladder, heart, kidney, lung, liver, pancreas, muscles, central nervous system, among others, which makes it a multi-systemic disease ( Goldberg & Bedaiwy, 2007 ; Lee et al., 2008 ). Endometriotic lesions are more frequent in the peritoneum and pelvic organs, especially in the ovaries, followed by the recto-vaginal septum. It is found less frequently in extra-pelvic regions, such as gastrointestinal (sigmoid, rectum, ileocecal and appendix) and urinary tract, extremities, subcutaneous tissue and abdominal wall ( Lee et al., 2008 ). The mechanism of impaired fertility in endometriosis may involve anatomical distortions in the pelvis, adhesions, endometriomas or the production of substances (prostaglandins, cytokines, and growth factors) that are harmful to normal ovarian function, ovulation, fertilization and implantation. The really valid mechanisms are tubal obstruction, pelvic adhesions and ovarian endometriomas that distort anatomical relationships, limit the access of oocytes and spermatozoa and alter fimbriae mobility, mainly in stages III and IV ( Mahutte & Arici, 2002 ). Phenomena such as anovulation, endocrine dysfunction, luteinized unruptured follicle syndrome, inadequate luteal phase, autoimmune dysfunction, abnormalities of the ovule quality and sperm alterations are theoretical mechanisms, still unproven, used to explain infertility in endometriosis in stages I and II ( Toya et al., 2000 ). However, the two most probable mechanisms to explain the infertility in these stages are maturing on the late follicular phase and the antispermatic effect impairing folliculogenesis with oocyte alterations. There are very few publications about the effect of endometriosis on tubal permeability. Some time ago Bowman & Cooke (1994) found that there was a strong correlation between the degree of intratubal damage and the extent of pelvic adhesions when the etiology was a previous pelvic inflammatory disease (PID), but not when the underlying etiology was endometriosis. However, in the endometriosis subgroup, intraluminal ampullary pathology was noted in 3 of 11 tubes (27%) assessed, and intraluminal fimbrial pathology was noted in 4 of 11 tubes (36%) assessed. Osuga et al. (2008) describe a case of a patient with endometriosis who sought infertility treatment. During ovarian stimulation, an image of hydrosalpinx without infection appears and changed dramatically in size with the menstrual cycle. The patient was 32 years old and had had endometriosis since 24 years of age. She underwent ethanol sclerotherapy of a bilateral ovarian endometrioma at age 26 and laparoscopic cystectomy for ovarian endometrioma at age 30. Serum Chlamydia trachomatis IgA and IgM antibodies were negative. During ultrasonography work-up to check follicular growth and ovulation, the author noticed a hydrosalpinx-like structure that appeared larger at each ultrasound scan. This structure was minimal during the menstrual period. It would reach its maximum size during ovulation, and then shrank again. A later laparoscopy revealed endometriosis and tubal obstruction. Salpingectomy was undertaken to improve the IVF-ET outcome. Histologically, they found endometriosis at the tubal wall serosa layer.

Results

The mean age of the patients was 33.7 years (4.76 SD). The mean infertility duration time was 66.7 months (120.6 SD). The endometriosis prevalence was 20/144 (13%). Among 144 women, the risk group (endometriosis II/IV) with tubal obstruction comprised 7out of 20 (35%), compared with the group without risk that comprised 22 out of 124 (17%). The X 2 test was 3.19 with a p -value of 0.07. The odds ratio (OR) was 2.5 (95% CI: 0.647-9.639) ( Figure 1 ). Figure 1 Endometriosis and Tubal Obstruction Endometriosis and Tubal Obstruction

Discussion

Due to diagnostic difficulties and the different types, the literature has few high quality publications on endometriosis. Broeze et al. (2012) for example, state that this disease is a condition that may result in tubal pathology, but information on endometriosis was either not documented in the original databases or not reported in a standardized way, or was in sufficient detail. For these reasons the author could even included endometriosis as a clinical variable in a meta-analysis. Removing endometriomas without hydrosalpinx or tubal obstruction remains controversial. Some authors state that this procedure did not improve the results of in vitro fertilization ( Garcia-Velasco et al., 2004 ). Nevertheless assisted reproductive technology is better than surgery, and should be offered as a first-line treatment ( Feinberg et al., 2008 ). Osuga et al. (2008) published a case of hydrosalpinx and endometrioma without apparent infection. Salpingectomy was undertaken to improve the IVF-ET outcome. However most of the hydrosalpinx was an infection sequel, mainly Chlamydia. This publication did not find an association between endometriosis III and IV and tubal obstruction, thought the statistical test almost reached significance. Further studies with larger data sets are needed to check these results.

Conclusions

Although the OR was 2.5 ( p =0.07) there was no significant difference between the groups with and without endometriosis III/IV. Further studies with larger samples are needed.

Materials|Methods

A case-control study was performed, involving 144 women with and without tubal obstruction. We calculated the odds ratio, with a 95% CI, of the patients with endometriosis III/IV having tubal obstruction. Calculations were performed using the SPSS package v.17.0. The statistical test was the Chi Square, with a p value of 0.05.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: pmc-nxml

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisinfertility

MeSH descriptors

Endometriosis Fallopian Tube Diseases Infertility, Female Adult Case-Control Studies Endometriosis Fallopian Tube Diseases Female Humans Infertility, Female Risk Factors

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-09-11T06:15:56.568227+00:00
pubmed
last seen: 2026-05-13T22:22:48.502547+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine